ABBV vs DIS: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and The Walt Disney Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
AbbVie Inc. · Healthcare
$216.63
+3.8% upside to fair value
Grade C
High Quality
VS
The Walt Disney Company · Communication Services
$103.89
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
DIS has more upside to fair value
(+45.0%).
DIS trades at a lower forward P/E
(16.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
DIS |
| Current Price |
$216.63 |
$103.89 |
| Fair Value Estimate |
$224.76 |
$150.64 |
| Upside to Fair Value |
+3.8%
|
+45.0%
|
| Market Cap |
$382.7B |
$180.4B |
| Forward P/E |
106.2x
|
16.6x
|
| EV / EBITDA |
26.4x
|
11.4x
|
| Price / Sales |
6.1x
|
1.9x
|
| Price / FCF |
18.3x
|
25.4x
|
| Revenue Growth YoY |
+12.4%
|
+6.5%
|
| Gross Margin |
70.7%
|
37.2%
|
| Operating Margin |
27.6%
|
15.5%
|
| Return on Equity |
68.0%
|
10.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.45%
|
3.94%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in pharmaceuticals with a strong focus on immunology, aesthetics, neuroscience, and oncology. The company benefits from a durable competitive moat driven by its immunology franchises, global commercial scale, and R&D capabilities, although it faces challenges from the post-Humira patent cliff and intense competition in biologics and small m…
The Walt Disney Company operates as a diversified entertainment conglomerate with strong positions in media networks, parks and experiences, and sports. The company benefits from a durable competitive moat driven by its iconic brand, extensive content library, and integrated ecosystem spanning streaming, theatrical, and physical experiences. Despite a 31.4% decline in earnings in the most recent …
Accumulation Zones
| Metric |
ABBV |
DIS |
| Zone Low |
$168.57 |
$112.98 |
| Zone High |
$191.05 |
$128.04 |
| In Buy Zone? |
No
|
Yes
|